Skip to content
Checked.be
Complete company report
Generated 17-08-2026
Active BE 0439.621.618Public limited company

BAUSCH & LOMB PHARMA

Stoeterijlaan 156 ·1150 Sint-Pieters-Woluwe, Belgium· 36 yrs active
Sector: Groothandel in farmaceutische en medische artikelen (46460)
Conclusion Checked

The computed 12-month bankruptcy probability of BAUSCH & LOMB PHARMA is 0.9% (low). The company has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 36 yrs
Board 3
Locations 2
Publications 19
Bankruptcy probability (12 mo) Checked model v1 · free
0.9% Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region +Long track record −Multiple establishment units +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Long-established
Founded in 1989, 36 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 16-07-2025 2025-00304938
31-12-2023 volledig 10-07-2024 2024-00237077
31-12-2022 volledig 07-07-2023 2023-00233574
31-12-2021 volledig 26-07-2022 2022-20267665
31-12-2020 volledig 31-08-2021 2021-65900012
31-12-2019 volledig 28-09-2020 2020-57400076
31-12-2018 volledig 19-06-2019 2019-21600546
31-12-2017 volledig 06-12-2018 2018-74300518
31-12-2016 volledig 18-12-2017 2017-72500117
31-12-2015 volledig 27-10-2016 2016-67000059
Directors & mandates 9 directors
Current directors & mandates
  • PANDA Manoj Kumar
    Director
    State Gazette act 22363823 (07-10-2022)
    Current
    07-10-2022 → present
  • Eberhard Kuehne
    Director
    State Gazette act 24108563 (18-07-2024)
    Current
    30-03-2018 → present
    2 events
    • 18-07-2024 Appointed· Director
    • 30-03-2018 Appointed· Director
  • Pierre Guibourg
    Director
    State Gazette act 22111695 (20-09-2022)
    Current
    12-12-2016 → present
    2 events
    • 20-09-2022 Appointed· Director
    • 12-12-2016 Appointed· Administrator
Historic, not recently confirmed (2)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • William Norman Woodfield
    Director
    State Gazette act 18086883 (05-06-2018)
    Not recently confirmed
    last confirmed in an act from 2018
  • PricewaterhouseCoopers Reviseurs d'Entreprises SC SCRLLegal entity
    Auditor
    State Gazette act 16169260 (12-12-2016)
    Not recently confirmed
    last confirmed in an act from 2016
Permanent representatives (1)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
  • Loris Guidi
    Représentant permanent du commissaire
    State Gazette act 25103660 (14-08-2025)
    Permanent representative
    14-08-2025 → present
Former directors (4)
  • WOODFIELD William
    Director
    State Gazette act 22363823 (07-10-2022)
    Former
    - → 07-10-2022
  • Linda Ann LaGorga
    Director
    State Gazette act 18086883 (05-06-2018)
    Former
    - → 05-06-2018
  • Marcin Jedrzejuk
    Director
    State Gazette act 18054485 (30-03-2018)
    Former
    - → 30-03-2018
  • Ling Zeng
    Director
    State Gazette act 17175995 (15-12-2017)
    Former
    - → 15-12-2017
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Statutory auditor 3 auditor
Statutory auditor IRE/IBR number Tenure
PwC Reviseurs d'EntreprisesCurrent
Commissaire
 - 14-08-2025 → present
Show 2 earlier auditors
Loris Guidì
Commissaire
succeeded by PwC Reviseurs d'Entreprises in 2025
 - 20-09-2022 → 14-08-2025
PricewaterhouseCoopers Reviseurs d'Entreprises SCRL
Commissaire
succeeded by Loris Guidì in 2022
 - 19-07-2019 → 20-09-2022
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Groothandel in farmaceutische en medische artikelen(46460)
Legal form Public limited company(014)
Incorporation19-12-1989
StatusActive
Postal code1150
Establishment units 2 locations
BAUSCH & LOMB PHARMA
Stoeterijlaan 156, 1150 Sint-Pieters-Woluwede groothandel in medisch-chirurgisch materieel en tandheelkundige instrumenten en benodigdheden
since 19902.047.423.837
BAUSCH & LOMB PHARMA
Korte Keppestraat 19, 9320 AalstDiverse administratieve activiteiten ten behoeve van kantoren
since 20222.383.016.321
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (33.3%) Wallonia 1 (33.3%) Brussels 1 (33.3%)
Parcel (capakey) Region Area Buildings Height / fl.
41342B0932/00D000 Flanders 1.7 ha 1 · 1,485 m² 5.7 m
25112M0807/00K002 Wallonia 540 m² 1 · 149 m² 17.4 m · 5 fl.
21683D0358/00V056 Brussels 205 m² 1 · 75 m² 12.3 m · 3 fl.
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 29 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025
14-08-2025
State Gazette act Director changes
v3.2
16-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
18-07-2024
State Gazette act Director changes
v3.2
10-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
07-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
2022
07-10-2022
State Gazette act Statutes amendment
v3.2
20-09-2022
State Gazette act Director changes
v3.2
26-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
31-08-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
2020
28-09-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
11-03-2020
State Gazette act Director changes
v3.2
2019
27-08-2019
State Gazette act Miscellaneous
completed · Peter VAN MELKEBEKE
19-07-2019
State Gazette act Director changes
v3.2
27-06-2019
State Gazette act Miscellaneous
proposal · Julie Salteur, Louise-Anne Bertin
19-06-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
06-12-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
29-06-2018
State Gazette act Capital & shares
v3.2
29-06-2018
State Gazette act Capital & shares
v3.2
21-06-2018
State Gazette act Miscellaneous
Substantive delegation · Nathalie Van Landuyt
05-06-2018
State Gazette act Director changes
v3.2
03-05-2018
State Gazette act Miscellaneous
Substantive delegation · Nathalie Van Landuyt
30-03-2018
State Gazette act Director changes
v3.2
2017
18-12-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
15-12-2017
State Gazette act Director changes
v3.2
08-08-2017
State Gazette act Capital & shares
v3.2
2016
12-12-2016
State Gazette act Director changes
v3.2
27-10-2016
NBB filing Annual accounts filed
fiscal year 2015 · volledig
24-02-2016
State Gazette act Miscellaneous
other · Pierre De Pauw
12-02-2016
State Gazette act Miscellaneous
Substantive delegation · Pierre De Pauw
Belgian State Gazette reading coverage 0 of 27 acts read

We know of 27 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 19 acts
Capital history · 3
29-06-2018
v3.2
29-06-2018
v3.2
08-08-2017
v3.2
All acts · 19 updated 1 year ago
2025
14-08-2025 2 directors appointed Director changes
  • PwC Reviseurs d'Entreprises, Commissaire
  • Loris Guidi, Représentant permanent du commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Loris Guidi",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2024
18-07-2024 Eberhard Kuehne appointed as director Director changes
  • Eberhard Kuehne, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eberhard Kuehne",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Pausch \u0026 Lomb Pharma"
  }
}
2022
07-10-2022 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": true
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
20-09-2022 2 directors appointed Director changes
  • Loris Guidì, Commissaire
  • Pierre Guibourg, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Loris Guid\u00EC",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Pierre Guibourg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}
2020
11-03-2020 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2019
27-08-2019 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Peter VAN MELKEBEKE
Summary: completedNotary: Peter VAN MELKEBEKE · BruxellesFirm: Berquin Notaires
Technical details 
{
  "stage": "completed",
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2019-06-17",
    "act_kind_objet": "OPERATION ASSIMILEE A UNE FUSION PAR ABSORPTION DE \u0022BAUSCH \u0026"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-07-31",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "acquiring",
        "address": "1030 Schaerbeek, Boulevard Lambermont 430",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb",
        "role": "absorbed",
        "address": "1030 Schaerbeek, Boulevard Lambermont 430",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "719"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2019-01-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine entier de la soci\u00E9t\u00E9 absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9 \u00E0 titre universel \u00E0 la soci\u00E9t\u00E9 absorbante.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0439.621.618",
    "org_name": "NautaDutilh SPRL",
    "person_name": null,
    "org_rep_person_name": "Louise-Anne Bertin"
  },
  "summary_narrative": "Le 31 juillet 2019, l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme Bausch \u0026 Lomb Pharma, si\u00E9geant \u00E0 Schaerbeek, a approuv\u00E9 une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption, par laquelle Bausch \u0026 Lomb Pharma absorbe la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e Bausch \u0026 Lomb, \u00E9galement situ\u00E9e \u00E0 Schaerbeek. Le transfert porte sur l\u0027ensemble du patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e \u00E0 titre universel, avec effet comptable \u00E0 partir du 1er janvier 2019.",
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "deux procurations"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
19-07-2019 1 director appointed, 1 resigning Director changes
  • PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
  • PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}
27-06-2019 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Julie Salteur, Louise-Anne Bertin
Summary: proposalNotary: Julie Salteur, Louise-Anne Bertin · Bruxelles
Technical details 
{
  "stage": "proposal",
  "notary": {
    "name": "Julie Salteur, Louise-Anne Bertin",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-06-27",
    "filing_date": "2019-06-18",
    "act_kind_objet": "D\u00E9p\u00F4t d\u0027un projet commun de fusion par absorption simplifi\u00E9e"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-06-17",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma SA",
        "role": "acquiring",
        "address": "Boulevard Lambermont 430, 1030 Schaerbeek",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0461.095.240",
        "name": "Bausch \u0026 Lomb SPRL",
        "role": "absorbed",
        "address": "Boulevard Lambermont 430, 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "676, 1\u00B0",
      "719",
      "720 \u00A72"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027ensemble du patrimoine, tant actif que passif, de Bausch \u0026 Lomb SPRL est transf\u00E9r\u00E9 \u00E0 Bausch \u0026 Lomb Pharma SA par dissolution sans liquidation.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0461.095.240",
    "org_name": "NautaDutilh",
    "person_name": null,
    "org_rep_person_name": "Louise-Anne Bertin"
  },
  "summary_narrative": "Les soci\u00E9t\u00E9s Bausch \u0026 Lomb Pharma SA et Bausch \u0026 Lomb SPRL, toutes deux \u00E9tablies \u00E0 Bruxelles, ont conjointement r\u00E9dig\u00E9 un projet commun de fusion par absorption simplifi\u00E9e, conform\u00E9ment aux articles 676, 1\u00B0 et 719 du Code des soci\u00E9t\u00E9s. L\u0027op\u00E9ration pr\u00E9voit la transmission int\u00E9grale du patrimoine de Bausch \u0026 Lomb SPRL \u00E0 Bausch \u0026 Lomb Pharma SA, sans liquidation de la soci\u00E9t\u00E9 absorb\u00E9e, avec effet r\u00E9troactif au 1er janvier 2019. Le projet a \u00E9t\u00E9 d\u00E9pos\u00E9 au greffe du tribunal de commerce de Bruxelles le 18 juin 2019 et publi\u00E9 aux Annexes du Moniteur belge le 27 juin 2019.",
  "co_filed_documents": [
    "le-projet-commun-de-fusion-par-absorption-simplifi\u00E9e-sign\u00E9-le-17-juin-2019"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
2018
29-06-2018 Transaction in capital or shares Capital & shares
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
29-06-2018 Transaction in capital or shares Capital & shares
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
21-06-2018 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Nathalie Van Landuyt
Summary: Substantive delegationNotary: Nathalie Van Landuyt · Bruxelles
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Nathalie Van Landuyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2018-06-21",
    "filing_date": "2018-06-12",
    "act_kind_objet": "Publication conform\u00E9ment \u00E0 l\u0027article 556 C. Soc."
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2018-05-15",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "boulevard Lambermont 430 - 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Thibaut Willems",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Nathalie Van Landuyt",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556 C. Soc."
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le mandat concerne les formalit\u00E9s de d\u00E9p\u00F4t et de publication du proc\u00E8s-verbal, sans transfert de patrimoine.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nathalie Van Landuyt",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les actionnaires de Bausch \u0026 Lomb Pharma ont d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9, par \u00E9crit, le 15 mai 2018, de nommer Thibaut Willems, Nathalie Van Landuyt et/ou tout avocat du cabinet NautaDutilh, si\u00E9geant \u00E0 Bruxelles, en tant que mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Ces mandataires ont pour mission d\u0027accomplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent proc\u00E8s-verbal au greffe du tribunal de commerce de Bruxelles et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
05-06-2018 1 director appointed, 1 resigning Director changes
  • William Norman Woodfield, Bestuurder
  • Linda Ann LaGorga, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Linda Ann LaGorga",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "William Norman Woodfield",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
03-05-2018 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Nathalie Van Landuyt
Summary: Substantive delegationNotary: Nathalie Van Landuyt · Bruxelles
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Nathalie Van Landuyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": null,
    "act_kind_objet": "Publication conform\u00E9ment \u00E0 l\u0027article 556 C. Soc."
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2018-03-01",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma SA",
        "role": "other",
        "address": "boulevard Lambermont, 430 - 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Fr\u00E9d\u00E9ric Heremans",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Pierre De Pauw",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Silke Volckaert",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Nathalie Van Landuyt",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le mandat concerne l\u0027accomplissement de toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent proc\u00E8s-verbal au greffe du Tribunal de Commerce et \u00E0 sa publication au Moniteur belge, ainsi que l\u0027approbation et la signature de tout acte ou document relatif \u00E0 ces formalit\u00E9s.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nathalie Van Landuyt",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les actionnaires de Bausch \u0026 Lomb Pharma SA ont d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9, par \u00E9crit, le 1er mars 2018, de d\u00E9signer comme mandataires sp\u00E9ciaux Fr\u00E9d\u00E9ric Heremans, Pierre De Pauw, Silke Volckaert, Nathalie Van Landuyt et/ou tout avocat du cabinet NautaDutilh, pour agir au nom et pour le compte de la soci\u00E9t\u00E9 aux fins de remplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent acte au greffe du Tribunal de Commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
30-03-2018 1 director appointed, 1 resigning Director changes
  • Eberhard Kuehne, Bestuurder
  • Marcin Jedrzejuk, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marcin Jedrzejuk",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eberhard Kuehne",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2017
15-12-2017 Ling Zeng resigns as director Director changes
  • Ling Zeng, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Ling Zeng",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
08-08-2017 Transaction in capital or shares Capital & shares
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2016
12-12-2016 2 directors appointed Director changes
  • PricewaterhouseCoopers Reviseurs d'Entreprises SC SCRL, Auditor
  • Pierre Guibourg, Administrator
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SC SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Pierre Guibourg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}
24-02-2016 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Pierre De Pauw
Summary: otherNotary: Pierre De Pauw · Bruxelles
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Pierre De Pauw",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2016-02-24",
    "filing_date": "2016-01-26",
    "act_kind_objet": ""
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2016-01-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "Boulevard Lambermont 430, 1030 Schaerbeek",
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Fr\u00E9d\u00E9ric Heremans",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pierre De Pauw",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. L\u0027acte concerne uniquement la d\u00E9signation de mandataires sp\u00E9ciaux pour le d\u00E9p\u00F4t et la publication du proc\u00E8s-verbal.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Pierre De Pauw",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de Bausch \u0026 Lomb Pharma s\u0027est r\u00E9unie le 26 janvier 2016 et a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de d\u00E9signer Fr\u00E9d\u00E9ric Heremans, Pierre De Pauw et/ou tout avocat du cabinet NautaDutilh comme mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Leur mission est d\u0027accomplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent acte au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}
12-02-2016 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Pierre De Pauw
Summary: Substantive delegationNotary: Pierre De Pauw · Bruxelles
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Pierre De Pauw",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2016-02-12",
    "filing_date": "2016-01-26",
    "act_kind_objet": ""
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2016-01-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "Boulevard Lambermont 430, 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Le transfert concerne les pouvoirs de repr\u00E9sentation et de gestion n\u00E9cessaires au d\u00E9p\u00F4t du proc\u00E8s-verbal au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Pierre De Pauw",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de Bausch \u0026 Lomb Pharma, r\u00E9unie le 26 janvier 2016, a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de d\u00E9signer Pierre De Pauw, Fr\u00E9d\u00E9ric Heremans et tout avocat du cabinet NautaDutilh \u00E0 Bruxelles comme mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Leur mandat, irr\u00E9vocable et valable trois mois, couvre toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du proc\u00E8s-verbal au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primary activity highlighted.
Names & trade names
Legal nameFR BAUSCH & LOMB PHARMA
Registered office
Place Alphonse Bosch 19 bus 2
1300 Wavre, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 199 of 1,896 with filed accounts
BIOTECH BE 0444.513.386 · Sint-Pieters-Woluwe
CONGRESS PHARMA BE 0743.735.919 · Sint-Pieters-Woluwe
KAMO MANAGEMENT BE 0627.665.422 · Sint-Pieters-Woluwe
Logistik Brussels BE 0841.874.183 · Sint-Pieters-Woluwe
MED CONCEPT EUROPE BE 0412.045.013 · Sint-Pieters-Woluwe
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative